Effectiveness of mindfulness-based stress reduction intervention for health-related quality of life in drug-dependent males
- PMID: 25593709
- PMCID: PMC4270661
- DOI: 10.5812/ircmj.12608
Effectiveness of mindfulness-based stress reduction intervention for health-related quality of life in drug-dependent males
Abstract
Background: Nowadays drug dependence has become one of the main concerns worldwide. Indeed, drug dependence and abuse have become personal, social and, health problems that intensively threat human resources.
Objectives: This study aimed to examine the effect of mindfulness-based stress reduction (MBSR) on health-related quality of life (HRQOL) in drug-dependent males.
Patients and methods: An experimental research with pretest/posttest design and a control group was conducted on 49 drug-dependent males. The selected individuals were randomly allocated to the study groups (24 to the experimental and 25 to the control groups). Afterwards, the Short Form Health Survey for HRQOL (SF-36) questionnaire was completed by participants. Subsequently, the experiment group experienced eight 90-minute sessions of training in MBSR. At the end of the training, the subjects were evaluated once again by SF-36. The independent-samples t test and analysis of covariance (ANCOVA) were used to analyses data.
Results: The results suggested that the mean differences between groups regarding scales of role emotional, vitality, mental health, social functioning, and bodily pain were statistically significant (P < 0.05).
Conclusions: Using MBSR is recommended for improving HRQOL in drug-dependent males who are undergoing treatment for their drug dependence in addiction treatment center; however, more studies concerning different drugs as well as drug dependence in women must be performed.
Keywords: Drug Addiction; Health-Related Quality of Life; Mindfulness-Based Stress Reduction.
Figures
References
-
- Sadock BJ, Kaplan HI, Sadock VA. Kaplan & Sadock's Synopsis of Psychiatry: Behavioral Sciences/clinical Psychiatry. 7 ed. New York: Wolter Kluwer/Lippincott Williams & Wilkins; 2007.
-
- Hashemi A. A new way in fighting against opioid drug. Tehran: Commutate of fighting against opioid drug; 2004.
-
- Acquadro C, Berzon R, Dubois D, Leidy NK, Marquis P, Revicki D, et al. Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health. 2003;6(5):522–31. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources